Viral hepatitis is a significant global public health concern, affecting millions of people worldwide. The most common types of viral hepatitis are hepatitis A, B, C, D, and E, each caused by distinct viruses with unique characteristics. Hepatitis A and E typically spread through contaminated food and water, while hepatitis B, C, and D are primarily transmitted through blood-to-blood contact, unprotected sex, and from an infected mother to her newborn. These infections can lead to acute and chronic liver disease, with the potential for severe complications, including liver cirrhosis and hepatocellular carcinoma. Hepatitis B and C are particularly concerning due to their chronic nature and long-term impact on liver health. Chronic hepatitis can persist for years without symptoms, leading to gradual liver damage. Hepatitis B vaccination has proven effective in preventing new infections, while antiviral medications have been developed to manage chronic hepatitis B and C, reducing the risk of complications. Global efforts to combat viral hepatitis involve vaccination programs, screening initiatives, and the development of accessible and affordable treatment options.